Healthcare-associated pneumonia and aspiration pneumonia

Aging and Disease

Volumn 6, Issue 1, 2015, Pages 27-37

  Komiya, Kosaku ^a,b   Ishii, Hiroshi ^c   Kadota, Jun Ichi ^a  

^a OITA UNIVERSITY   (Japan)

^b Tenshindo Hetsugi Hospital   (Japan)

^c FUKUOKA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Aspiration pneumonia; Diagnosis; Elderly; Healthcare associated pneumonia

Indexed keywords

AGING; ASPIRATION PNEUMONIA; CLINICAL ASSESSMENT; DYSPHAGIA; HEALTH CARE ASSOCIATED PNEUMONIA; HEALTH CARE FACILITY; HUMAN; INFORMATION PROCESSING; MORTALITY; PATHOGENESIS; PRACTICE GUIDELINE; PREVALENCE; REVIEW;

EID: 84936068095     PISSN: None     EISSN: 21525250     Source Type: Journal    
DOI: 10.14336/AD.2014.0127     Document Type: Review

References (98)

1. American Thoracic Society; Infectious Diseases Society of America (2005). Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med, 171: 388-416.
2. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, et al. (2005). Epidemiology and outcomes of health-careassociated pneumonia: results from a large US database of culture-positive pneumonia. Chest, 128: 3854-3862.
3. Seymann GB, Di Francesco L, Sharpe B, Rohde J, Fedullo P, et al. (2009). The HCAP gap: differences between self-reported practice patterns and published guidelines for health care-associated pneumonia. Clin Infect Dis, 49: 1868-1874.
4. Grenier C, Pepin J, Nault V, Howson J, Fournier X, et al. (2011). Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia. J Antimicrob Chemother, 66: 1617-1624.
5. Attridge RT, Frei CR (2011). Health care-associated pneumonia: an evidence-based review. Am J Med, 124: 689-697.
6. Chalmers JD, Taylor JK, Singanayagam A, Fleming GB, Akram AR, et al. (2011). Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort study. Clin Infect Dis, 53: 107-113.
7. Ewig S, Welte T, Chastre J, Torres A (2010). Rethinking the concepts of community-acquired and health-careassociated pneumonia. Lancet Infect Dis, 10: 279-287.
8. Komiya K, Ishii H, Umeki K, Mizunoe S, Okada F, et al. (2013). Impact of aspiration pneumonia in patients with community-acquired pneumonia and healthcareassociated pneumonia: A multicenter retrospective cohort study. Respirology, 18: 514-521.
9. Polverino E, Cilloniz C, Dambrava P, Gabarrus A, Ferrer M, et al. (2013). Systemic corticosteroids for community-acquired pneumonia: reasons for use and lack of benefit on outcome. Respirology, 18: 263-271.
10. Falcone M, Corrao S, Licata G, Serra P, Venditti M (2012). Clinical impact of broad-spectrum empirical antibiotic therapy in patients with healthcare-associated pneumonia: a multicenter interventional study. Intern Emerg Med, 7: 523-531.
11. Teramoto S, Kawashima M, Komiya K, Shoji S (2009). Health-care-associated pneumonia is primarily due to aspiration pneumonia. Chest, 136: 1702-1703.
12. Marik PE (2001). Aspiration pneumonitis and aspiration pneumonia. N Engl J Med, 344: 665-671.
13. Marik PE, Kaplan D (2003). Aspiration pneumonia and dysphagia in the elderly. Chest, 124: 328-336.
14. Spickard A, 3rd, Hirschmann JV (1994). Exogenous lipoid pneumonia. Arch Intern Med, 154: 686-692.
15. Dikensoy O, Usalan C, Filiz A (2002). Foreign body aspiration: clinical utility of flexible bronchoscopy. Postgrad Med J, 78: 399-403.
16. Zissin R, Shapiro-Feinberg M, Rozenman J, Apter S, Smorjik J, et al. (2001). CT findings of the chest in adults with aspirated foreign bodies. Eur Radiol, 11: 606-611.
17. El-Solh AA, Pietrantoni C, Bhat A, Aquilina AT, Okada M, et al. (2003). Microbiology of severe aspiration pneumonia in institutionalized elderly. Am J Respir Crit Care Med, 167: 1650-1654.
18. Fernandez-Sabe N, Carratala J, Roson B, Dorca J, Verdaguer R, et al. (2003) Community-acquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes. Medicine (Baltimore), 82: 159-169.
19. Vergis EN, Brennen C, Wagener M, Muder RR (2001). Pneumonia in long-term care: a prospective case-control study of risk factors and impact on survival. Arch Intern Med, 161: 2378-2381.
20. Yamaya M, Yanai M, Ohrui T, Arai H, Sasaki H (2001). Interventions to prevent pneumonia among older adults. J Am Geriatr Soc, 49:85-90.
21. Ohrui T (2005). Preventive strategies for aspiration pneumonia in elderly disabled persons. Tohoku J Exp Med, 207: 3-12.
22. Sasaki H, Sekizawa K, Yanai M, Arai H, Yamaya M, et al. (1997). New strategies for aspiration pneumonia. Intern Med, 36: 851-855.
23. Fukuyama H, Yamashiro S, Tamaki H, Kishaba T (2013). A prospective comparison of nursing- and healthcare-associated pneumonia (NHCAP) with community-acquired pneumonia (CAP). J Infect Chemother, 19: 719-726.
24. Giannella M, Pinilla B, Capdevila JA, Martinez Alarcon J, et al. (2012). Pneumonia treated in the internal medicine department: focus on healthcare-associated pneumonia. Clin Microbiol Infect, 18: 786-794.
25. Simonetti A, Viasus D, Garcia-Vidal C, Adamuz J, Roset A, et al. (2012). Timing of antibiotic administration and outcomes of hospitalized patients with communityacquired and healthcare-associated pneumonia. Clin Microbiol Infect, 18: 1149-1155.
26. Garcia-Vidal C, Viasus D, Roset A, Adamuz J, Verdaguer R, et al. (2011). Low incidence of multidrugresistant organisms in patients with healthcareassociated pneumonia requiring hospitalization. Clin Microbiol Infect, 17: 1659-1665.
27. Nakagawa N, Saito Y, Sasaki M, Tsuda Y, Mochizuki H, et al. (2013). Comparison of clinical profile in elderly patients with nursing and healthcare-associated pneumonia, and those with community-acquired pneumonia. Geriatr Gerontol Int, in press.
28. Oshitani Y, Nagai H, Matsui H, Aoshima M (2013). Reevaluation of the Japanese guideline for healthcareassociated pneumonia in a medium-sized community hospital in Japan. J Infect Chemother, 19: 579-587.
29. Miyashita N, Akaike H, Teranishi H, Kawai Y, Ouchi K, et al. (2013). Evaluation of serological tests for diagnosis of Chlamydophila pneumoniae pneumonia in patients with nursing and healthcare-associated pneumonia. J Infect Chemother, 19: 249-255.
30. Ishida T, Tachibana H, Ito A, Yoshioka H, Arita M, et al. (2012). Clinical characteristics of nursing and healthcare-associated pneumonia: a Japanese variant of healthcare-associated pneumonia. Intern Med, 51: 2537-2544.
31. Webb BJ, Dangerfield BS, Pasha JS, Agrwal N, Vikram HR (2012). Guideline-concordant antibiotic therapy and clinical outcomes in healthcare-associated pneumonia. Respir Med, 106: 1606-1612.
32. Kaku N, Yanagihara K, Morinaga Y, Izumikawa K, Nagashima S, et al. (2013). The definition of healthcareassociated pneumonia (HCAP) is insufficient for the medical environment in Japan: a comparison of HCAP and nursing and healthcare-associated pneumonia (NHCAP). J Infect Chemother, 19: 70-76.
33. Miyashita N, Kawai Y, Akaike H, Ouchi K, Hayashi T, et al. (2012). Clinical features and the role of atypical pathogens in nursing and healthcare-associated pneumonia (NHCAP): differences between a teaching university hospital and a community hospital. Intern Med, 51: 585-594.
34. Madaras-Kelly KJ, Remington RE, Fan VS, Sloan KL (2012). Predicting antibiotic resistance to communityacquired pneumonia antibiotics in culture-positive patients with healthcare-associated pneumonia. J Hosp Med, 7: 195-202.
35. Hsu JL, Siroka AM, Smith MW, Holodniy M, Meduri GU (2011). One-year outcomes of community-acquired and healthcare-associated pneumonia in the Veterans Affairs Healthcare System. Int J Infect Dis, 15: e382-387.
36. Madaras-Kelly KJ, Remington RE, Sloan KL, Fan VS (2012). Guideline-based antibiotics and mortality in healthcare-associated pneumonia. J Gen Intern Med, 27: 845-852.
37. Dobler CC, Waterer G (2013). Healthcare-associated pneumonia: a US disease or relevant to the Asia Pacific, too? Respirology, 18: 923-932.
38. Falcone M, Blasi F, Menichetti F, Pea F, Violi F (2012). Pneumonia in frail older patients: an up to date. Intern Emerg Med, 7: 415-424.
39. Labelle A, Kollef MH (2012). Healthcare-associated pneumonia: approach to management. Clin Chest Med, 32: 507-515.
40. Falcone M, Venditti M, Shindo Y, Kollef MH (2011). Healthcare-associated pneumonia: diagnostic criteria and distinction from community-acquired pneumonia. Int J Infect Dis, 15: e545-550.
41. Polverino E, Torres A (2009). Current perspective of the HCAP problem: is it CAP or is it HAP? Semin Respir Crit Care Med, 30: 239-248.
42. Morrow LE (2009). Prevention strategies for healthcareassociated pneumonia. Semin Respir Crit Care Med, 30: 86-91.
43. Restrepo MI, Anzueto A (2009). The role of gramnegative bacteria in healthcare-associated pneumonia. Semin Respir Crit Care Med, 30: 61-66.
44. Polverino E, Torres A (2009). Diagnostic strategies for healthcare-associated pneumonia. Semin Respir Crit Care Med, 30: 36-45.
45. Poch DS, Ost DE (2009). What are the important risk factors for healthcare-associated pneumonia? Semin Respir Crit Care Med, 30: 26-35.
46. Carratala J, Garcia-Vidal C (2008). What is healthcareassociated pneumonia and how is it managed? Curr Opin Infect Dis, 21: 168-173.
47. Chroneou A, Zias N, Beamis JF, Jr., Craven DE (2007). Healthcare-associated pneumonia: principles and emerging concepts on management. Expert Opin Pharmacother, 8: 3117-3131.
48. Fujitani S, Yu VL (2006). A new category--healthcareassociated pneumonia: a good idea, but problems with its execution. Eur J Clin Microbiol Infect Dis, 25: 627-631.
49. Mylotte JM (2006). Nursing home-acquired pneumonia: update on treatment options. Drugs Aging, 23: 377-390.
50. Craven DE (2006). What is healthcare-associated pneumonia, and how should it be treated? Curr Opin Infect Dis, 19: 153-160.
51. Carratala J, Mykietiuk A, Fernandez-Sabe N, Suarez C, Dorca J, et al. (2007). Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med, 167: 1393-1399.
52. Shindo Y, Sato S, Maruyama E, Ohashi T, Ogawa M, et al. (2009). Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital. Chest, 135: 633-640.
53. Kohno S, Imamura Y, Shindo Y, Seki M, Ishida T, et al (2013). Clinical practice guidelines for nursing- and healthcare-associated pneumonia (NHCAP) [complete translation]. Respir Investig, 51: 103-126.
54. R. S. Fraser NLM, Neil Colman, P.D. Pare (1999). General Features of Pulmonary Infection. Fraser and Pare's Diagnosis of Diseases of the Chest, W.B. Saunders. Volume II.
55. Gleeson K, Eggli DF, Maxwell SL (1997). Quantitative aspiration during sleep in normal subjects. Chest, 111: 1266-1272.
56. Parrilla C, Valenza V, Calo L, Passali GC, Castaldi P, et al. (2008). Is it sufficient to quantify aspiration for predicting aspiration pneumonia? Clin Nucl Med, 33: 236-239.
57. Hirose M, Komiya K, Kadota J (2014). Influence of appetite and continuation of meals on the prognosis of elderly patients who have lost swallowing function. J Palliat Med, in press.
58. Teramoto S, Yamamoto H, Yamaguchi Y, Ouchi Y, Matsuse T (2004). A novel diagnostic test for the risk of aspiration pneumonia in the elderly. Chest, 125: 801-802.
59. Nakagawa T, Sekizawa K, Nakajoh K, Tanji H, Arai H, et al. (2000). Silent cerebral infarction: a potential risk for pneumonia in the elderly. J Intern Med, 247: 255-259.
60. Holas MA, DePippo KL, Reding MJ (1994). Aspiration and relative risk of medical complications following stroke. Arch Neurol, 51: 1051-1053.
61. Galovic M, Leisi N, Muller M, Weber J, Abela E, et al. (2013). Lesion location predicts transient and extended risk of aspiration after supratentorial ischemic stroke. Stroke, 44: 2760-2767.
62. Yoshino A, Ebihara T, Ebihara S, Fuji H, Sasaki H (2001). Daily oral care and risk factors for pneumonia among elderly nursing home patients. JAMA, 286: 2235-2236.
63. Yoneyama T, Yoshida M, Ohrui T, Mukaiyama H, Okamoto H, et al. (2002). Oral care reduces pneumonia in older patients in nursing homes. J Am Geriatr Soc, 50: 430-433.
64. Quagliarello V, Ginter S, Han L, Van Ness P, Allore H, et al. (2005). Modifiable risk factors for nursing homeacquired pneumonia. Clin Infect Dis, 40: 1-6.
65. Pae M, Meydani SN, Wu D (2012). The role of nutrition in enhancing immunity in aging. Aging Dis, 3: 91-129.
66. Hazeldine J, Lord JM (2013). The impact of ageing on natural killer cell function and potential consequences for health in older adults. Ageing Res Rev, in press.
67. Bulow M (2012). Videofluoroscopic swallow study: techniques, signs and reports. Nestle Nutr Inst Workshop Ser, 72: 43-52.
68. Ott DJ, Pikna LA (1993). Clinical and videofluoroscopic evaluation of swallowing disorders. AJR Am J Roentgenol,161: 507-513.
69. Robbins J (1996). Normal swallowing and aging. Semin Neurol, 16: 309-317.
70. Matsuse T, Oka T, Kida K, Fukuchi Y (1996). Importance of diffuse aspiration bronchiolitis caused by chronic occult aspiration in the elderly. Chest, 110: 1289-1293.
71. Kikuchi R, Watabe N, Konno T, Mishina N, Sekizawa K, et al. (1994). High incidence of silent aspiration in elderly patients with community-acquired pneumonia. Am J Respir Crit Care Med, 150: 251-253.
72. Esayag Y, Nikitin I, Bar-Ziv J, Cytter R, Hadas-Halpern I, et al. (2010). Diagnostic value of chest radiographs in bedridden patients suspected of having pneumonia. Am J Med, 123:e81-85.
73. Komiya K, Ishii H, Umeki K, Kawamura T, Okada F, et al. (2013). Computed tomography findings of aspiration pneumonia in 53 patients. Geriatr Gerontol Int, 13: 580-585.
74. Ewig S, Welte T, Torres A (2012). Is healthcareassociated pneumonia a distinct entity needing specific therapy? Curr Opin Infect Dis, 25: 166-175.
75. Jeong BH, Koh WJ, Yoo H, Um SW, Suh GY, et al. (2013) Performances of prognostic scoring systems in patients with healthcare-associated pneumonia. Clin Infect Dis, 56: 625-632.
76. Carrabba M, Zarantonello M, Bonara P, Hu C, Minonzio F, et al. (2012). Severity assessment of healthcare-associated pneumonia and pneumonia in immunosuppression. Eur Respir J, 40: 1201-1210.
77. Lujan M, Gallego M, Rello J (2009). Healthcareassociated infections. A useful concept? Curr Opin Crit Care, 15: 419-424.
78. Riquelme R, Torres A, El-Ebiary M, de la Bellacasa JP, Estruch R, et al. (1996). Community-acquired pneumonia in the elderly: A multivariate analysis of risk and prognostic factors. Am J Respir Crit Care Med, 154: 1450-1455.
79. Allewelt M, Schuler P, Bolcskei PL, Mauch H, Lode H (2004). Ampicillin + sulbactam vs clindamycin +/-cephalosporin for the treatment of aspiration pneumonia and primary lung abscess. Clin Microbiol Infect, 10: 163-170.
80. Kadowaki M, Demura Y, Mizuno S, Uesaka D, Ameshima S, et al. (2005). Reappraisal of clindamycin IV monotherapy for treatment of mild-to-moderate aspiration pneumonia in elderly patients. Chest, 127: 1276-1282.
81. Ott SR, Allewelt M, Lorenz J, Reimnitz P, Lode H, German Lung Abscess Study G (2008). Moxifloxacin vs ampicillin/sulbactam in aspiration pneumonia and primary lung abscess. Infection, 36: 23-30.
82. Galvin S, Dolan A, Cahill O, Daniels S, Humphreys H (2012). Microbial monitoring of the hospital environment: why and how? J Hosp Infect, 82: 143-151.
83. Steele CM (2012). Exercise-based approaches to dysphagia rehabilitation. Nestle Nutr Inst Workshop Ser, 72: 109-117.
84. Van der Maarel-Wierink CD, Vanobbergen JN, Bronkhorst EM, Schols JM, de Baat C (2011). Risk factors for aspiration pneumonia in frail older people: a systematic literature review. J Am Med Dir Assoc, 12: 344-354.
85. Arai T, Yasuda Y, Takaya T, Toshima S, Kashiki Y, et al. (1998). ACE inhibitors and symptomless dysphagia. Lancet, 352: 115-116.
86. Sekizawa K, Matsui T, Nakagawa T, Nakayama K, Sasaki H (1998). ACE inhibitors and pneumonia. Lancet, 352: 1069.
87. Bosch X, Formiga F, Cuerpo S, Torres B, Roson B, et al. (2012). Aspiration pneumonia in old patients with dementia. Prognostic factors of mortality. Eur J Intern Med, 23: 720-726.
88. Teramoto S, Yamamoto H, Yamaguchi Y, Ishii M, Hibi S, et al. (2008). Antiplatelet cilostazol, an inhibitor of type III phosphodiesterase, improves swallowing function in patients with a history of stroke. J Am Geriatr Soc, 56: 1153-1154.
89. Talaie H, Jabari HR, Shadnia S, Pajouhmand A, Nava-Ocampo AA, et al. (2008). Cefepime/clindamycin vs. ceftriaxone/clindamycin for the empiric treatment of poisoned patients with aspiration pneumonia. Acta Biomed, 79: 117-122.
90. Komiya K, Kadota JI (2013). C-reactive protein as a prognostic factor in elderly patients with aspiration pneumonia. Eur J Intern Med, 24:e88-9.
91. Falcone M, Corrao S, Venditti M, Serra P, Licata G (2011). Performance of PSI, CURB-65, and SCAP scores in predicting the outcome of patients with community-acquired and healthcare-associated pneumonia. Intern Emerg Med, 6: 431-436.
92. Komiya K, Ishii H, Kushima H, Sato S, Kimura H, et al. (2013). Physicians' attitudes toward the definition of "death from age-related physical debility" in deceased elderly with aspiration pneumonia. Geriatr Gerontol Int, 13: 586-590.
93. Finucane TE, Christmas C, Travis K (1999). Tube feeding in patients with advanced dementia: a review of the evidence. JAMA, 282: 1365-1370.
94. Dharmarajan TS, Unnikrishnan D, Pitchumoni CS (2001). Percutaneous endoscopic gastrostomy and outcome in dementia. Am J Gastroenterol, 96: 2556-2563.
95. Galicia-Castillo M (2006). The PEG dilemma: feeding tubes are not the answer in advanced dementia. Geriatrics, 61: 12-13.
96. Komiya K, Ishii H, Okabe E, Iwashita T, Miyajima H, et al. (2013). Risk factors for unexpected death from suffocation in elderly patients hospitalized for pneumonia. Geriatr Gerontol Int, 13:388-392.
97. Komiya K, Ishii H, Teramoto S, Yasuda T, Sato S, et al. (2012). Medical professionals' attitudes toward tube feeding for themselves or their families: a multicenter survey in Japan. J Palliat Med, 15: 561-566.
98. Solomon MZ, O'Donnell L, Jennings B, Guilfoy V, Wolf SM, et al. (1993). Decisions near the end of life: professional views on life-sustaining treatments. Am J Public Health, 83: 14-23.